Microdosing LSD For Pain Tolerance

There has been a massive transformation in the use of LSD in recent years. Microdosing psychedelics like LSD has become more popular among professionals who want to reap the psychological and mood-enhancing effects of these drugs without the significant tripping that comes with regular doses. Some of these favorable side effects include better mood and productivity and reduced symptoms of despair and anxiety. Another key benefit of microdosing LSD is to enhance pain tolerance in patients. In this article, we’ll discuss how microdosing LSD helps raise pain tolerance levels in patients.

Microdosing LSD For Pain Tolerance

Microdosing LSD is fast becoming an important aspect of raising pain tolerance levels in patients. However, to experience some good side effects while staying below the dosage threshold that would cause you to trip, microdosing LSD entails swallowing a very little amount of the substance.

LSD is a well-known psychedelic. However, new research has looked into the drug’s potential in a completely different context: as a painkiller. If a future LSD pain cure is developed, it will be beneficial in and of itself. It could also help to dispel the stigma around LSD while also providing an alternative to pharmaceutical painkillers such as opioids, which help most pain patients but are linked to difficulties in the minority.

LSD can be used medicinally in the therapy of persistent pain. A controlled study on the usefulness of LSD in pain management has focused on non-hallucinogenic, low doses of LSD, which are more tolerable and thus preferable to treatment with large doses of LSD that generate full-blown psychedelic effects which can enhance pain tolerance in patients.

How LSD Enhances Pain Tolerance

The participants in the study were 24 healthy people who were given single doses of five, ten, and twenty micrograms of LSD or a placebo. The researchers used a low-risk examination called the Cold Pressor Test to determine pain tolerance levels.

Participants were instructed to immerse their hands in a tank filled with cold water set at three degrees for as long as they could stand it. Researchers looked at how long individuals could stand in the cold water (which gave them an idea of their pain tolerance) and subjective assessments of unpleasantness, stress, and pain.

Researchers discovered that a 20 microgram dose of LSD considerably reduced pain perception compared to a placebo. Lower doses of LSD did not produce the same results.

The subjects’ pain tolerance increased by about 20% after receiving the 20 micrograms dose, and they were able to keep their hands immersed for much longer. These benefits were shown to be just as significant five hours after the dosage as they were one and a half hours after the administration, implying that this amount could have a “halo” effect for pain relief.

The researchers also discovered that the 20 microgram dose caused minor psychological and cognitive impairment, which did not impede routine operations.

This research also found that low doses of LSD could constitute a useful pain management treatment option that is effective in patients and devoid of the problematic consequences associated with current mainstay drugs, such as opioids.

These findings offer a lot of hope because it has long been suspected that LSD could alter pain feelings and our relationship with pain. We must continue to research this to develop safer, non-addictive pain management options and help people in pain live happier, healthier, and more fully expressed lives.

While such research is still in its early stages, it’s encouraging to see that pain management can be approached non-opioid. As more people continue to microdose LSD for greater pain tolerance effects, more clinical trials would be required to investigate and reproduce these findings in greater detail and on a wider scale. So, if you’re on the waiting list for a prescription LSD painkiller, you’ll most likely have to wait years. LSD is classified as a Schedule I narcotic in the United States, meaning it is deemed “extremely addictive” and cannot be prescribed by doctors.

In the 1960s, as LSD use grew in popularity and became more closely associated with counter-cultural and anti-Vietnam War activities, governments in the United States and worldwide responded by outlawing it. For decades, the passage of the Controlled Substances Act and equivalent legislation essentially delayed any clinical LSD study. However, there is hope it will see the light of the day in the not too distant future.